Please login to the form below
autophagy
This page shows the latest autophagy news and features for those working in and with pharma, biotech and healthcare.
Morning brief: New biotech launched, Merck and Moderna expand collaboration and more
Autophagy is the natural process by which cells break down surplus or dysfunctional protein; organelles such as mitochondria; and viruses and other pathogens. ... When autophagy fails, dysfunctional material builds up and fuels a cascade of problems,
Latest news
-
Yoshinori Ohsumi wins Nobel Prize in Medicine for autophagy work
The 2016 Nobel Prize in Physiology or Medicine has been awarded to Yoshinori Ohsumi for his discoveries of mechanisms for autophagy. ... Similarly, mutations in autophagy genes have been linked with various cancers, with Ohsumi's work prompting current
-
Michael J Fox Foundation reveals USD 1.2m Parkinsonís drug target funding
Awards went to the following research programmes:. Dr Asa Abeliovich of Columbia University is targeting the autophagy cellular pathway involved in clearing away protein such as alpha-synuclein, whose clumping is ... Abeliovich will test small-molecule
More from news
Approximately 1 fully matching, plus 2 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- New study identifies drugs that are safe to use in COVID-19 treatment
- Novacyt launches diagnostic test to differentiate between COVID-19 and flu
- How COVID-19 is accelerating the threat of antimicrobial resistance
- Relief Therapeutics seeks US emergency approval for COVID-19 drug
- Lilly’s Verzenio scores a win in early-stage breast cancer
- Pfizer’s ALK inhibitor Lorbrena hits the mark in head-to-head lung cancer trial
- Live Webinar: Leveraging Digital Technologies to Create Valuable KOL Engagements & Empower Patients
- Live Webinar: Harnessing Technology to Improve Health and Healthcare
- Novavax starts first phase 3 COVID-19 vaccine trial in the UK
- Lilly’s Verzenio scores a win in early-stage breast cancer
- FDA sets January decision date for Xalkori in ALK-positive lymphoma
- Q&A: Isabel Gibson
PMHub
COUCH Health
We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...
Latest intelligence
- Surviving cancer: a new era for patients
- Now more than ever, a shift in perspective is needed...
- Crisis? No problem!
- Issues planning & management for pharma spokespeople, by Andrew Smith...
- Are patient recruitment and retention rates rising or falling?
- First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....
Quick links
Infographics
